title: Catheter-related Saccharomyces cerevisiae Fungemia Following Saccharomyces boulardii Probiotic Treatment: In a child in intensive care unit and review of the literature.
abstract: AlthoughSaccharomyces boulardiiis usually a non-pathogenic fungus, in rare occasions it can cause invasive infection in children. We present the case of an 8-year-old patient in pediatric surgical intensive care unit who developedS. cerevisiaefungemia following probiotic treatment containingS. boulardii. Caspofungin was not effective in this case and he was treated with amphotericin B. We want to emphasize that physicians should be careful about probiotic usage in critically ill patients.
authors.affiliation: Department of Pediatrics and Division of Pediatric Infectious Diseases, Medical School, Marmara University, Istanbul, Turkey.
authors.forename: Serkan
authors.initials: S
authors.lastname: Atıcı
authors.affiliation: Department of Pediatrics and Division of Pediatric Infectious Diseases, Medical School, Marmara University, Istanbul, Turkey.
authors.forename: Ahmet
authors.initials: A
authors.lastname: Soysal
authors.affiliation: Department of Pediatric Surgery, Medical School, Marmara University, Istanbul, Turkey.
authors.forename: Kıvılcım
authors.initials: K
authors.lastname: Karadeniz Cerit
authors.affiliation: Department of Microbiology, Medical School, Marmara University, Istanbul, Turkey.
authors.forename: Şerife
authors.initials: Ş
authors.lastname: Yılmaz
authors.affiliation: Department of Microbiology, Medical School, Marmara University, Istanbul, Turkey.
authors.forename: Burak
authors.initials: B
authors.lastname: Aksu
authors.affiliation: Department of Pediatric Surgery, Medical School, Marmara University, Istanbul, Turkey.
authors.forename: Gürsu
authors.initials: G
authors.lastname: Kıyan
authors.affiliation: Department of Pediatrics and Division of Pediatric Infectious Diseases, Medical School, Marmara University, Istanbul, Turkey.
authors.forename: Mustafa
authors.initials: M
authors.lastname: Bakır
keywords: Fungemia; Intensive care unit; Probiotic treatment; Saccharomyces boulardii; Saccharomyces cerevisiae